| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Vascular Biology |
Dependent and Independent Pathways
From the Institute of Medicine (E.D., R.K.B.), Section of Medical Biochemistry, University of Bergen, Haukeland University Hospital, Bergen; and the Research Institute for Internal Medicine (A.Y., T.U., B.H., J.K.D., P.A.), Section of Endocrinology (T.U.), and Section of Clinical Immunology and Infectious Diseases (P.A.), Medical Department, Rikshospitalet, University of Oslo, Oslo, Norway.
Correspondence to Endre Dyrøy, Section of Medical Biochemistry, Institute of Medicine University of Bergen, Haukeland University Hospital N-5021, Bergen, Norway. E-mail endre.dyroy{at}med.uib.no
Objective Tetradecylthioacetic acid (TTA) is a hypolipidemic antioxidant with immunomodulating properties involving activation of peroxisome proliferatoractivated receptors (PPARs). Human endothelial cells express PPARs. We hypothesized that TTA could modulate endothelial cell activation at least partly through PPAR-related mechanisms.
Methods and Results We explored this hypothesis by different experimental approaches involving both in vitro studies in human endothelial cells (HUVECs) and in vivo studies in humans and PPAR-
/ mice. Our main findings were as follows: (1) TTA suppressed the tumor necrosis factor
induced expression of vascular cell adhesion molecule 1 (VCAM-1) and interleukin 8 (IL-8) in HUVECs. (2) No TTA-mediated attenuation of VCAM-1 and chemokine expression was seen in the liver of PPAR-
/ mice. (3) Whereas TTA markedly enhanced PPAR-
target genes in the liver of wild-type, but not of PPAR-
/, mice, no such effect on PPAR-
target genes was seen in HUVECs. (4) The relevance of our findings to human disease was suggested by a TTA-mediated downregulation of serum levels of soluble VCAM-1 and IL-8 in psoriasis patients.
Conclusion We show that TTA has the ability to attenuate tumor necrosis factor
mediated endothelial cell activation, further supporting antiinflammatory effects of this fatty acid, possibly involving both PPAR-
dependent and independent pathways.
We show that tetradecylthioacetic acid attenuates tumor necrosis factor-
mediated endothelial cell activation, supporting antiinflammatory effects of this fatty acid. The relevance of our findings to human diseases was suggested by a tetradecylthioacetic acidmediated downregulation of inflammatory mediators in psoriasis patients.
Key Words: endothelial dysfunction inflammation cytokine peroxisome proliferatoractivated receptors
This article has been cited by other articles:
![]() |
A. H. V. Remels, R. C. J. Langen, H. R. Gosker, A. P. Russell, F. Spaapen, J. W. Voncken, P. Schrauwen, and A. M. W. J. Schols PPAR{gamma} inhibits NF-{kappa}B-dependent transcriptional activation in skeletal muscle Am J Physiol Endocrinol Metab, July 1, 2009; 297(1): E174 - E183. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. M. Bivol, M. Hultstrom, O. A. Gudbrandsen, R. K. Berge, and B. M. Iversen Tetradecylthioacetic acid downregulates cyclooxygenase 2 in the renal cortex of two-kidney, one-clip hypertensive rats Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2008; 295(6): R1866 - R1873. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. M. Bivol, R. K. Berge, and B. M. Iversen Tetradecylthioacetic acid prevents the inflammatory response in two-kidney, one-clip hypertension Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2008; 294(2): R438 - R447. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Cuzzocrea, E. Mazzon, R. Di Paola, A. Peli, A. Bonato, D. Britti, T. Genovese, C. Muia, C. Crisafulli, and A. P. Caputi The role of the peroxisome proliferator-activated receptor-{alpha} (PPAR-{alpha}) in the regulation of acute inflammation J. Leukoc. Biol., May 1, 2006; 79(5): 999 - 1010. [Abstract] [Full Text] [PDF] |
||||
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2005 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |